---
title: Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-FT4BGF6N" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Ebrahimi, N., Faghihkhorasani, F., Seifollahy Fakhr, S., Moghaddam, P. R., Yazdani, E., Kheradmand, Z., Rezaei-Tazangi, F., Adelian, S., Mobarak, H., Hamblin, M. R., &#38; Aref, A. R. (2022). Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer. <i>Cellular and Molecular Life Sciences (CMLS)</i>, <i>79</i>(11). <a href="https://doi.org/10.1007/s00018-022-04552-3">https://doi.org/10.1007/s00018-022-04552-3</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-FT4BGF6N" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=2075025" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/FT4BGF6N" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-FT4BGF6N" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-FT4BGF6N" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-FT4BGF6N" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
    <a href="https://doi.org/10.1007/s00018-022-04552-3" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://doi.org/10.1007/s00018-022-04552-3" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-FT4BGF6N"></div>
</article>
<div id="csl-bib-meta-FT4BGF6N" class="csl-bib-meta">
  <article id="about-article-FT4BGF6N" class="about_pub-article">
    <h1>Om</h1>
    Ebrahimi et al. undersøkte korleis små partiklar kalla eksosomar, som finst i kroppsvæsker som blod, spytt og urin, kan hjelpe til med å diagnostisere kreft. Eksosomar ber viktige molekyl frå sine opphavsceller, inkludert ikkje-kodande RNA (ncRNA), som spelar avgjerande roller i cellefunksjonar og tumorvekst. Fordi eksosomar er rikeleg til stades og enkle å få tilgang til, kan dei tene som pålitelege markørar for tidleg påvising av kreft, forutsjå pasientutfall, overvake behandlingsresponsar og vurdere risikoen for tilbakefall av kreft. Forfattarane påpeiker likevel at det framleis er utfordringar med å standardisere metodar for å isolere og identifisere desse eksosomane for klinisk bruk. Denne forskinga framhevar potensialet for å bruke eksosomar i kreftdiagnose og behandling, noko som kan betydeleg forbetre pasientomsorg.
  </article>
  <article id="keywords-article-FT4BGF6N" class="keywords-article">
    <h1>Emneord</h1>
    Tumor-avleia eksosomar, Ikkje-kodande RNA, Diagnostiske biomarkørar, Kreft, Ekstracellulære vesiklar, Translasjonsforsking
  </article>
  <article id="abstract-article-FT4BGF6N" class="abstract-article">
    <h1>Samandrag</h1>
    Almost all clinical oncologists agree that the discovery of reliable, accessible, and non-invasive biomarkers is necessary to decrease cancer mortality. It is possible to employ reliable biomarkers to diagnose cancer in the early stages, predict the patient prognosis, follow up the response to treatment, and estimate the risk of disease recurrence with high sensitivity and specificity. Extracellular vesicles (EVs), especially exosomes, have been the focus of translational research to develop such biomarkers over the past decade. The abundance and distribution of exosomes in bodily fluids, including serum, saliva, and urine, as well as their ability to transport various biomolecules (nucleic acids, proteins, and lipids) derived from their parent cells, make exosomes reliable, accessible, and potent biomarkers for diagnosis and follow-up of solid and hematopoietic tumors. In addition, exosomes play a vital role in various cellular processes, including tumor progression, by participating in intercellular communication. Although these advantages underline the high potential of tumor-derived exosomes as diagnostic biomarkers, the lack of standardized effective methods for their isolation, identification, and precise characterization makes their application challenging in clinical settings. We discuss the importance of non-coding RNAs (ncRNAs) in cellular processes, and the role of tumor-derived exosomes containing ncRNAs as potential biomarkers in several types of cancer. In addition, the advantages and challenges of these studies for translation into clinical applications are covered.
  </article>
  <article id="sdg-article-FT4BGF6N" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_nn.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="{{< params subfolder >}}nn/archive/?sdg=3#archive" class="sdg-publication-count"><span>1358</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/god-helse-og-livskvalitet?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-FT4BGF6N" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li><a href="{{< params subfolder >}}nn/archive/?key=3DCRN523">Universitetet i Innlandet</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=T77LXH6D">Fakultet for anvendt økologi, landbruksfag og bioteknologi</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=VL6KDQ85">Institutt for bioteknologi</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=ZLN3ADWB">2022</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=R3VTKJWE">November</a></li>
    </ul>
  </article>
</div>
